These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34380020)

  • 1. EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines.
    Steeg R; Mueller SC; Mah N; Holst B; Cabrera-Socorro A; Stacey GN; De Sousa PA; Courtney A; Zimmermann H
    Stem Cell Reports; 2021 Aug; 16(8):1853-1867. PubMed ID: 34380020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience.
    De Sousa PA; Steeg R; Wachter E; Bruce K; King J; Hoeve M; Khadun S; McConnachie G; Holder J; Kurtz A; Seltmann S; Dewender J; Reimann S; Stacey G; O'Shea O; Chapman C; Healy L; Zimmermann H; Bolton B; Rawat T; Atkin I; Veiga A; Kuebler B; Serano BM; Saric T; Hescheler J; Brüstle O; Peitz M; Thiele C; Geijsen N; Holst B; Clausen C; Lako M; Armstrong L; Gupta SK; Kvist AJ; Hicks R; Jonebring A; Brolén G; Ebneth A; Cabrera-Socorro A; Foerch P; Geraerts M; Stummann TC; Harmon S; George C; Streeter I; Clarke L; Parkinson H; Harrison PW; Faulconbridge A; Cherubin L; Burdett T; Trigueros C; Patel MJ; Lucas C; Hardy B; Predan R; Dokler J; Brajnik M; Keminer O; Pless O; Gribbon P; Claussen C; Ringwald A; Kreisel B; Courtney A; Allsopp TE
    Stem Cell Res; 2017 Apr; 20():105-114. PubMed ID: 28334554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EBiSC iPSC bank for disease studies.
    Steeg R; Neubauer JC; Müller SC; Ebneth A; Zimmermann H
    Stem Cell Res; 2020 Dec; 49():102034. PubMed ID: 33099110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Management of Data for the Banking, Qualification, and Distribution of Induced Pluripotent Stem Cells: Lessons Learned from the European Bank for Induced Pluripotent Stem Cells.
    Mah N; Kurtz A; Fuhr A; Seltmann S; Chen Y; Bultjer N; Dewender J; Lual A; Steeg R; Mueller SC
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Human iPSCs by Reprogramming with the Unmodified Synthetic mRNA.
    Annand RR
    Methods Mol Biol; 2021; 2239():163-174. PubMed ID: 33226619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs.
    Durruthy JD; Sebastiano V
    Methods Mol Biol; 2015; 1283():31-42. PubMed ID: 25304205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and implementation of large-scale quality control for the European bank for induced Pluripotent Stem Cells.
    O'Shea O; Steeg R; Chapman C; Mackintosh P; Stacey GN
    Stem Cell Res; 2020 May; 45():101773. PubMed ID: 32252012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a human iPSC line by mRNA reprogramming.
    Artero Castro A; León M; Del Buey Furió V; Erceg S; Lukovic D
    Stem Cell Res; 2018 Apr; 28():157-160. PubMed ID: 29499498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scalable expansion of iPSC and their derivatives across multiple lineages.
    Kwok CK; Sébastien I; Hariharan K; Meiser I; Wihan J; Altmaier S; Karnatz I; Bauer D; Fischer B; Feile A; Cabrera-Socorro A; Rasmussen M; Holst B; Neubauer JC; Clausen C; Verfaillie C; Ebneth A; Hansson M; Steeg R; Zimmermann H
    Reprod Toxicol; 2022 Sep; 112():23-35. PubMed ID: 35595152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human-Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions.
    Rivera T; Zhao Y; Ni Y; Wang J
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e117. PubMed ID: 32649060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells Using the GFP-Marked Lentiviral Vectors in the Chemically Defined Medium.
    Shao Z; Cevallos RR; Hu K
    Methods Mol Biol; 2021; 2239():101-116. PubMed ID: 33226615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
    Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
    Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of two induced pluripotent stem cell (iPSC) lines from human breast milk using episomal reprogramming system.
    Tang C; Lu C; Ji X; Ma L; Zhou Q; Xiong M; Zhou W
    Stem Cell Res; 2019 Aug; 39():101511. PubMed ID: 31404746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling.
    Liu C; Ameen M; Himmati S; Thomas D; Sayed N
    Methods Mol Biol; 2021; 2239():153-162. PubMed ID: 33226618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A poor imitation of a natural process: a call to reconsider the iPSC engineering technique.
    Zhang Y; Yao L; Yu X; Ou J; Hui N; Liu S
    Cell Cycle; 2012 Dec; 11(24):4536-44. PubMed ID: 23114619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells.
    Shafa M; Walsh T; Panchalingam KM; Richardson T; Menendez L; Tian X; Suresh Babu S; Dadgar S; Beller J; Yang F; Baghbaderani BA
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group.
    Song HW; Solomon JN; Masri F; Mack A; Durand N; Cameau E; Dianat N; Hunter A; Oh S; Schoen B; Marsh M; Bravery C; Sumen C; Clarke D; Bharti K; Allickson JG; Lakshmipathy U
    Cytotherapy; 2024 Nov; 26(11):1275-1284. PubMed ID: 38970614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical Cord Tissue as a Source of Young Cells for the Derivation of Induced Pluripotent Stem Cells Using Non-Integrating Episomal Vectors and Feeder-Free Conditions.
    Mohamed A; Chow T; Whiteley J; Fantin A; Sorra K; Hicks R; Rogers IM
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.
    Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH
    Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies.
    Silva M; Daheron L; Hurley H; Bure K; Barker R; Carr AJ; Williams D; Kim HW; French A; Coffey PJ; Cooper-White JJ; Reeve B; Rao M; Snyder EY; Ng KS; Mead BE; Smith JA; Karp JM; Brindley DA; Wall I
    Cell Stem Cell; 2015 Jan; 16(1):13-7. PubMed ID: 25575079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.